20325011000001109: Catumaxomab (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Catumaxomab

\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Catumaxomab

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

68411001000001117 Catumaxomab (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

68411101000001116 Catumaxomab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Catumaxomab	Is a	Virtual therapeutic moiety	true	Inferred relationship	Existential restriction modifier
Catumaxomab	Is a	Product containing monoclonal antibody	true	Inferred relationship	Existential restriction modifier
Catumaxomab	Has active ingredient	Monoclonal antibody	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Catumaxomab 10micrograms/0.1ml solution for infusion pre-filled syringes	Is a	True	Catumaxomab	Inferred relationship	Existential restriction modifier
Catumaxomab 50micrograms/0.5ml solution for infusion pre-filled syringes	Is a	True	Catumaxomab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets